Discovering and Evaluating New Epigenetic Drugs

Jean-Pierre J. Issa, MD of Fox Chase Cancer Center Fels Institute for Cancer Research & Molecular Biology at Temple University discusses the importance of discovering and evaluating new epigenetic drugs for cancer research. This was recorded at the American Association for Cancer Research (AACR) 2017 Annual Meeting in Washington, DC.